Actresses Emma Stone, Olivia Wilde named the new faces of Revlon
NEW YORK — Revlon has signed celebrities Emma Stone and Olivia Wilde as global brand ambassadors for the Revlon brand.
As brand ambassadors for Revlon, Stone and Wilde will become the faces of new and existing Revlon products, and will appear in global, multimedia campaigns that span television, print, in-store and digital and social platforms. Their first campaigns will be tied to the launch of new color cosmetics and nail enamel products and will premiere in early 2012.
In addition to starring in Revlon’s global advertising campaigns, the actresses’ involvement in the brand will be multilayered. For example, both already have pledged their commitment to Revlon’s philanthropic efforts, lending their star power to raise awareness for a variety of causes that support women, according to the manufacturer. Revlon has raised more than $65 million for women’s cancer research over the last 10 years.
“We are absolutely thrilled to welcome Emma and Olivia into the Revlon family,” stated Alan Ennis, Revlon president and CEO. “These remarkably talented actresses personify the Revlon woman — glamorous, confident and bold. Together, they will help us build meaningful connections with new consumers and strengthen our relationship with existing fans of our brand. Each has a unique style, personality and look that appeals to a broad range of women.”
Between them, Stone and Wilde have six major feature films slated for worldwide launch in 2011, including the recently released “Crazy Stupid Love” (Stone), “Cowboys and Aliens” (Wilde) and “The Change-Up” (Wilde), and the anticipated “The Help” (Stone) and “In Time” (Wilde).
Stone and Wilde have appeared on more than 15 magazine covers so far this year and have worked with Gucci Westman, the makeup artist who serves as Revlon’s global artistic director. Westman is creating the beauty looks for Stone’s and Wilde’s first Revlon campaigns. In the months and weeks leading up to the debut of the campaigns, Revlon Facebook fans and Twitter followers will receive exclusive sneak peeks of the Westman-created looks.
Innopharma gets FDA nod for epilepsy generic
PISCATAWAY, N.J. — The Food and Drug Administration has approved a generic drug for epilepsy.
Innopharma announced the FDA approval of levetiracetam injection. The drug is a generic version of UCB’s Keppra.
Innopharma has a licensing agreement with X-GEN Pharmaceuticals for marketing and distribution of the drug.
More research supports omega-3, heart health connection
DENVER — Omega-3 polyunsaturated fats, or PUFAs, found in seafood may reduce arterial stiffness and improve heart function in chronic heart failure, according to new research released Wednesday.
"The consumption of nearly 1 g of omega-3s per day may improve the elasticity of the arteries, especially in individuals at high risk of heart disease," PUFA Newsletter editor Joyce Nettleton said. "Measurement of arterial stiffness is a powerful predictor of future heart events and the risk of dementia and death."
Other studies showed that a high dose (4 g/day) of omega-3s is linked to improved heart function in people with severe chronic heart failure. Further, eating baked or broiled fish regularly may substantially lower the chance of heart failure in women after menopause. Choosing fattier types of fish, such as salmon, mackerel, sardines and tuna, may be even more favorable, according to Nettleton.
DHA, found in fattier fish, also proved beneficial when given to animals up to five hours after a stroke. "Whether similar results would be obtained in humans is the pot-of-gold question waiting for clinical evaluation," Nettleton noted.
These findings and more are summarized in the August 2011 PUFA Newsletter and Fats of Life newsletters for health professionals and consumers, respectively.
To read the complimentary PUFA Newsletter and Fats of Life newsletters, go to Fatsoflife.com.